Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter stud...

by Thanapirom K., Suksawatamnuay S., Sukeepaisarnjareon W., Tanwandee T., Charatcharoenwitthaya P., Thongsawat S., Leerapun A., Piratvisuth T., Boonsirichan R., Bunchorntavakul C., Pattanasirigool C., Pornthisarn B., Tantipanichtheerakul S., Sripariwuth E., Jeamsripong W., Sanpajit T., Poovorawan Y., Komolmit P.
Published 2017

Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions

by Ahn, S.H., Chan, H.L.Y., Chen, P.-J., Cheng, J., Goenka, M.K., Hou, J., Lim, S.G., Omata, M., Piratvisuth, T., Xie, Q., Yim, H.J., Yuen, M.-F.
Published 2011

Practical difficulties in the management of hepatitis B in the Asia-Pacific region

by Mohamed, R., Desmond, P., Suh, Dong-Jin, Amarapurkar, D., Gane, E., Guangbi, Y., Hou, Jin-Lin, Jafri, W., Lai, C.L., Lee, Chang-Hong, Lee, Shou-Dong, Lim, S.G., Guan, R., Phiet, P.H., Piratvisuth, T., Sollano, J., Wu, J.C.
Published 2004

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: Results from the 2-year roadmap strategy

by Teerha Piratvisuth, Piyawat Komolmit, Henry L.Y. Chan, Tawesak Tanwandee, Wattana Sukeepaisarnjaroen, Mário G. Pessoa, Eduardo Fassio, Suzane K. Ono, Fernando Bessone, Jorge Daruich, Stefan Zeuzem, Michael Manns, Alkaz Uddin, Yuhong Dong, Aldo Trylesinski
Published 2018

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B

by Lau G.K.K., Piratvisuth T., Kang X.L., Marcellin P., Thongsawat S., Cooksley G., Gane E., Fried M.W., Wan C.C., Seung W.P., Wen Y.C., Berg T., Flisiak R., McCloud P., Pluck N.
Published 2014

Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter stud...

by Kessarin Thanapirom, Sirinporn Suksawatamnuay, Wattana Sukeepaisarnjareon, Tawesak Tanwandee, Phunchai Charatcharoenwitthaya, Satawat Thongsawat, Apinya Leerapun, Teerha Piratvisuth, Rattana Boonsirichan, Chalermrat Bunchorntavakul, Chaowalit Pattanasirigool, Bubpha Pornthisarn, Supot Tantipanichtheerakul, Ekawee Sripariwuth, Woramon Jeamsripong, Teeranan Sanpajit, Yong Poovorawan, Piyawat Komolmit
Published 2018

Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter stud...

by Kessarin Thanapirom, Sirinporn Suksawatamnuay, Wattana Sukeepaisarnjareon, Tawesak Tanwandee, Phunchai Charatcharoenwitthaya, Satawat Thongsawat, Apinya Leerapun, Teerha Piratvisuth, Rattana Boonsirichan, Chalermrat Bunchorntavakul, Chaowalit Pattanasirigool, Bubpha Pornthisarn, Supot Tantipanichtheerakul, Ekawee Sripariwuth, Woramon Jeamsripong, Teeranan Sanpajit, Yong Poovorawan, Piyawat Komolmit
Published 2018

Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: A multicentre study

by Kessarin Thanapirom, Sirinporn Suksawatamnuay, Wattana Sukeepaisarnjaroen, Sombat Treeprasertsuk, Tawesak Tanwandee, Phunchai Charatcharoenwitthaya, Satawat Thongsawat, Apinya Leerapun, Teerha Piratvisuth, Rattana Boonsirichan, Chalermrat Bunchorntavakul, Chaowalit Pattanasirigool, Bubpha Pornthisarn, Supoj Tuntipanichteerakul, Ekawee Sripariwuth, Woramon Jeamsripong, Theeranun Sanpajit, Yong Poovorawan, Piyawat Komolmit
Published 2018

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B

by George K.K. Lau, Teerha Piratvisuth, Xian Luo Kang, Patrick Marcellin, Satawat Thongsawat, Graham Cooksley, Edward Gane, Michael W. Fried, Cheng Chow Wan, Woon Paik Seung, Yu Chang Wen, Thomas Berg, Robert Flisiak, Philip McCloud, Nigel Pluck
Published 2018

Vitamin D-binding protein gene polymorphism predicts pegylated interferon-related HBsAg seroclearance in HBeAg-negative Thai chronic hepatitis B patients: A multicentre study

by Kessarin Thanapirom, Sirinporn Suksawatamnuay, Wattana Sukeepaisarnjaroen, Sombat Treeprasertsuk, Tawesak Tanwandee, Phunchai Charatcharoenwitthaya, Satawat Thongsawat, Apinya Leerapun, Teerha Piratvisuth, Rattana Boonsirichan, Chalermrat Bunchorntavakul, Chaowalit Pattanasirigool, Bubpha Pornthisarn, Supot Tuntipanichteerakul, Ekawee Sripariwuth, Woramon Jeamsripong, Theeranan Sanpajit, Yong Poovorawan, Piyawat Komolmit
Published 2019

Practical difficulties in the management of hepatitis B in the Asia-Pacific region

by Mohamed, R., Desmond, P., Suh, D.-J., Amarapurkar, D., Gane, E., Guangbi, Y., Hou, J.-L., Jafri, W., Ching, L.L., Lee, C.-H., Lee, S.-D., Seng, G.L., Guan, R., Pham, H.P., Piratvisuth, T., Sollano, J., Wu, J.-C.
Published 2016

Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection

by Colvin,R.A., Tanwandee,T., Piratvisuth,T., Thongsawat,S., Hui,A., Zhang,H., Ren,H., Chen,P., Chuang,W., Sobhonslidsuk,A., Li,R., Qi,Y., Præstgaard,J.T., Han,Y., Xu,J., Stein,D.S., Chien,R., Flisiak,R., Jabłkowski,M.S., Liaw,Y., Sung,J.J.Y.
Published 2015

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

by Pianko S., Zeuzem S., Chuang W.-L., Foster G.R., Sarin S.K., Flisiak R., Lee C.-M., Andreone P., Piratvisuth T., Shah S., Sood A., George J., Gould M., Komolmit P., Thongsawat S., Tanwandee T., Rasenack J., Li Y., Pang M., Yin Y., Feutren G., Jacobson I.M.
Published 2014

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

by Pianko S., Zeuzem S., Chuang WL., Foster GR., Sarin SK., Flisiak R., Lee CM., Andreone P., Piratvisuth T., Shah S., Sood A., George J., Gould M., Komolmit P., Thongsawat S., Tanwandee T., Rasenack J., Li Y., Pang M., Yin Y., Feutren G., Jacobson IM., for the B2202 Study Team.
Published 2014

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

by S. Pianko, S. Zeuzem, W. L. Chuang, G. R. Foster, S. K. Sarin, R. Flisiak, C. M. Lee, P. Andreone, T. Piratvisuth, S. Shah, A. Sood, J. George, M. Gould, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, Y. Li, M. Pang, Y. Yin, G. Feutren, I. M. Jacobson
Published 2018

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

by Y. F. Liaw, J. D. Jia, H. L.Y. Chan, K. H. Han, T. Tanwandee, W. L. Chuang, D. M. Tan, X. Y. Chen, E. Gane, T. Piratvisuth, L. Chen, Q. Xie, J. J.Y. Sung, C. Wat, C. Bernaards, Y. Cui, P. Marcellin
Published 2018

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin

by G. R. Foster, S. Zeuzem, S. Pianko, S. K. Sarin, T. Piratvisuth, S. Shah, P. Andreone, A. Sood, W. L. Chuang, C. M. Lee, J. George, M. Gould, R. Flisiak, I. M. Jacobson, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, R. Sola, I. Messina, Y. Yin, S. Cammarata, G. Feutren, K. K. Brown
Published 2018

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin

by G. R. Foster, S. Zeuzem, S. Pianko, S. K. Sarin, T. Piratvisuth, S. Shah, P. Andreone, A. Sood, W. L. Chuang, C. M. Lee, J. George, M. Gould, R. Flisiak, I. M. Jacobson, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, R. Sola, I. Messina, Y. Yin, S. Cammarata, G. Feutren, K. K. Brown
Published 2018

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

by Lau, George, Yu, Ming-Lung, Wong, Grace, Thompson, Alexander, Ghazinian, Hasmik, Hou, Jin-Lin, Piratvisuth, Teerha, Jia, Ji-Dong, Mizokami, Masashi, Cheng, Gregory, Chen, Guo-Feng, Liu, Zhen-Wen, Baatarkhuu, Oidov, Cheng, Ann Lii, Ng, Woon Leung, Lau, Patrick, Mok, Tony, Chang, Jer-Ming, Hamid, Saeed, Dokmeci, A. Kadir, Gani, Rino A., Payawal, Diana A., Chow, Pierce, Park, Joong-Won, Strasser I, Simone, Mohamed, Rosmawaiti, Win, Khin Maung, Tawesak, Tanwandee, Sarin, Shiv Kumar, Omata, Masao

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

by George Lau, Ming Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin Lin Hou, Teerha Piratvisuth, Ji Dong Jia, Masashi Mizokami, Gregory Cheng, Guo Feng Chen, Zhen Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer Ming Chang, Saeed Hamid, A. Kadir Dokmeci, Rino A. Gani, Diana A. Payawal, Pierce Chow, Joong Won Park, Simone I. Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tanwandee Tawesak, Shiv Kumar Sarin, Masao Omata
Published 2022